Companies/JP/4521

科研製薬株式会社 · KAKEN PHARMACEUTICAL CO., LTD.

Income flow

Annual
4521 ANNUAL Income StatementPeriod 2026-03-31Source ANNUAL
MedicineJPY 74BReal EstateJPY 3BRevenueJPY 77B-18% Y/YGross profitJPY 40B-32% Y/YCost of revenueJPY 37B

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2026-03-31 · ANNUAL · JPY
By activity
By activityJPY 76.9B
  • MedicineJPY 74.3B96.7%
  • Real EstateJPY 2.5B3.3%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).5.02%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.4.02%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).190PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.336.8%Shares outTotal shares currently outstanding (issued and not retired).37.9MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).32.5M
Upcoming dividend
Next ex-div
2027-03-30 · declared
Last cash
95 · 2027-03-30
Stock splits
  1. 1:22015-09-28